FinCanna Capital Corp. and Astar Minerals Ltd. (TSX.V: TAR) this morning announced that FinCanna will share 50 percent of the profits from Cultivation Technologies’ interim medical cannabis extraction facility operating in Coachella, California.
Cannabis News
Global Payout, Inc. (GOHE) Subsidiary Sells Front Cover of First PotSaver Los Angeles Edition
MoneyTrac Technology, Inc. has successfully sold the front cover of PotSaver’s premier Los Angeles edition, which is slated for release and mass distribution on January 1, 2018.
EVIO, Inc. (EVIO) Expands Testing Capabilities at Yuba City Laboratory
EVIO, Inc. this morning announced that it has expanded testing capabilities at its Yuba City laboratory in Northern California.
Grey Cloak Tech, Inc. (GRCK) Announces Cancellation of Reverse Stock Split
Grey Cloak Tech, Inc. (OTCQB: GRCK) today announced that its board of directors has decided to abandon and cancel the reverse stock split that was previously approved by both the board and the company’s shareholders in February 2017.
Global Payout, Inc. (GOHE) Subsidiary Ramping-Up Sales and Marketing Efforts for PotSaver Brand
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., is currently in the process of ramping-up its sales and marketing efforts within Los Angeles County for its newly-acquired PotSaver brand.
PotNetwork Holding, Inc. (POTN) Subsidiary Enhances Product Line
PotNetwork Holding, Inc. (OTC: POTN) this morning announced that its wholly owned subsidiary, Diamond CBD, Inc., has enhanced its product line with a selection of premium honey products.
Canopy Growth Applauds Action by TSX to Confirm That Listed Companies Should Not be Engaging in Federally Illegal US Cannabis Activities
TSX Staff Notice on Marijuana Validates Canopy's Longstanding Market Strategy to Protect Investors by Conducting Business Only Where it is Federally Legal to Do So; Should Bring Clarity and Relief to Investors Seeking to Participate in Listed and Compliant Cannabis Companies
InMed Provides Updates On Cannabinoid-Based Drug Therapies For The Treatment Of Pain
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), announced today additional pre-clinical results in the development of INM-405 for the treatment of pain.
California Wildfires Torch Cannabis Farms at Height of Harvest Season
Just months before California is poised to legalize recreational marijuana, fatal wildfires tearing through three northern counties have scorched an untold number of cannabis farms.
Taking Stock of InMed - InMed President and CEO Eric Adams Sits Down For Two In-Depth Interviews
InMed Pharmaceuticals Inc. (CNSX:IN) (OTCMKTS:IMLFF) CEO Eric Adams recently sat down for two separate interviews regarding InMed's proprietary biosynthesis process, their patent filings and their research on using cannabinoids to treat various diseases.
Plus Receives $2M Series A for Cannabis-Infused Products
Plus, the cannabis infused products manufacturer, is pleased to announce the closing of its Series A financing. The Financing was comprised of $2 Million USD of Series A Preferred Stock (the “Shares”), and was led by The Green Opportunity Funds.
Cannabis Wheaton Announces Strategic Alliance With Large Convenience Store Group
Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) announceS that it has entered an exclusive strategic alliance with the corporate owner of a national chain of convenience stores to develop and implement cannabis distribution and retail sale opportunities at all Convenience Store Group locations.
InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) Biosynthesis Technology Demonstrates Robust Diversity
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast track with its proprietary technology for the microbial biosynthesis of cannabinoids
5 CANNABIS BIOTECH STOCKS TO WATCH
These 5 Biotechs including InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) have a combined market cap of over $4 Billion. What should investors know about future growth for these companies?
Aurora Cannabis Announces $6 Million Private Placement
Aurora Cannabis Inc. has agreed to a one-time special accommodation for the benefit of its underwriters due to very significant demand for the Bought Deal, to proceed with a concurrent, non-commissioned, non-brokered private placement of up to 2,000,000 units of the Company (the "Units") at a price of $3.00 per Unit (the "Offering").